BCYC Bicycle Therapeutics plc

NASDAQ
$3.56

Bicycle Therapeutics plc (BCYC) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Subdued Selling ran below BCYC's own trailing one-year pace, with 11% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 5 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
6 transactions
Purchases
$0
0 shares
Sales
$13.0K
3,004 shares
Net activity
-$13.0K
purchases less sales

How much of that selling was preplanned? 11% planned / 89% discretionary

10b5-1 plan sales $1.4K 1 transaction · 333 shares
Discretionary sales $11.5K 5 transactions · 2,671 shares

Largest single sale: $7.5K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Lee Kevin CHIEF EXECUTIVE OFFICER Sell 1,737 $4.31 $7.5K 603,671 −0.3% of holding
Skynner Michael CHIEF SCIENTIFIC OFFICER Sell 532 $4.31 $2.3K 157,171 −0.3% of holding
Perry Jennifer Scott Chief Operating Officer Sell 10b5-1 333 $4.34 $1.4K 91,052 −0.4% of holding
Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF Sell 255 $4.31 $1.1K 94,375 −0.3% of holding
Thompson Travis Alvin Chief Financial Officer Sell 104 $4.31 $448 64,441 −0.2% of holding
Perry Jennifer Scott Chief Operating Officer Sell 43 $4.31 $185 91,385 −0% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.